Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy (Q44252110)

1 December 2017

Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy (English)

1 reference

1 December 2017

1 reference

1

1 reference

1 December 2017

Katarzyna Karwacz

2

1 reference

1 December 2017

Frederick Arce

3

1 reference

1 December 2017

Arianna Yglesias Rivera

4

1 reference

1 December 2017

Luis Enrique Fernández

5

1 reference

1 December 2017

Mary K Collins

6

1 reference

1 December 2017

Belinda Sánchez Ramírez

7

1 reference

1 December 2017

1 March 2012

1 reference

1 December 2017

Journal of Gene Medicine

1 reference

1 December 2017

14

1 reference

1 December 2017

3

1 reference

1 December 2017

151-157

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 December 2017

1 reference

Human squamous cell lung cancers express increased epidermal growth factor receptors

21 January 2018

1 reference

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

21 January 2018

1 reference

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

21 January 2018

1 reference

Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

21 January 2018

1 reference

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant

21 January 2018

1 reference

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

21 January 2018

1 reference

Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection

21 January 2018

1 reference

Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine

21 January 2018

1 reference

Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.

21 January 2018

1 reference

Targeting dendritic cell signaling to regulate the response to immunization

21 January 2018

1 reference

Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy

21 January 2018

1 reference

Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques

21 January 2018

1 reference

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization

21 January 2018

1 reference

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

21 January 2018

1 reference

Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice

21 January 2018

1 reference

Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response

21 January 2018

1 reference

Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

21 January 2018

1 reference

Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses

21 January 2018

1 reference

T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies.

21 January 2018

1 reference

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

SYFPEITHI: database for MHC ligands and peptide motifs

21 January 2018

1 reference

High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter

21 January 2018

1 reference

Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.

21 January 2018

1 reference

Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

21 January 2018

1 reference

Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

21 January 2018

1 reference

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.

21 January 2018

1 reference

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

21 January 2018

1 reference

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

21 January 2018

1 reference

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JGM.2606

1 reference

1 December 2017

1 reference